Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trial.
📚 期刊: European journal of heart failure
📅 发表: 0000-00-00
🔬 PMID: 42148667 👁️ 浏览: 14
👤 作者: van de Bovenkamp, Nassiri, de Man, Oosterveer, Mourmans, van Raalte, Dijkmans, van Heerebeek, van Empel, Eringa, Bakermans, Handoko
心血管
📝 摘要
Iron deficiency (ID) is common in patients with heart failure with preserved ejection fraction (HFpEF). The IRON-HFpEF trial aimed to evaluate the mechanistic effects of intravenous iron supplementation on cardiovascular function and exercise tolerance in HFpEF.